FacebookTwitterLinkedInGoogle+RSS Feed
Fire EMSEMS TodayEMS Insider

Medtronic and FDA Agreement

ST. PAUL, Minn. -- Fridley (Minn.) based Medtronic and the U.S. Food and Drug Administration have reached an agreement that could allow the company's Washington-based division for external defibrillators to resume unrestricted distribution of products, the company said today.

Medtronic's Physio-Control unit indefinitely suspended shipments of external defibrillators and other emergency-response gear in January 2007 because of quality control problems at a factory in Redmond, Wash. The quality issues were related to manufacturing processes, rather than individual products, and no devices were recalled as a result.

On Friday, Medtronic gave notice to a court in Washington state that it had reached agreement on a consent decree with FDA regarding quality system improvements for its external defibrillators. Those products, including the LifePak models commonly found in airports, health clubs and other public spaces, are used by paramedics, hospital workers and, in some cases, the general public to aid those suffering sudden cardiac arrest.

Medtronic said in a statement today that the agreement with FDA outlines actions Physio-Control must take to resume unrestricted distribution of its external defibrillators.

When Medtronic suspended product shipments, the company had only just announced plans to spin off the Physio-Control unit because the business wasn't growing as quickly as others at Medtronic. The external defibrillator business is separate from the Minnesota-based unit for implantable cardiac defibrillators.


Thorough Assessment is Crucial in Patients with Respiratory Distress

Accurate observation and treatment go a long way when considering all causes of respiratory distress.

Oklahoma City & Tulsa EMS Become First System to Adopt ResQCPR as a Standard of Care

Today the Medical Control Board for the EMS System for Metropolitan Oklahoma City and Tulsa, Okla., unanimously voted to approve the ResQCPR system by ZOLL a...

Tilt Angle Significantly Affects CPR

Test on pigs show patient tilt angle can have a positive effect on cerebral perfusion.

ZOLL ResQCPR™ System Receives Premarket Approval from the FDA

Chelmsford, Mass.— ZOLL® Medical Corporation, a manufacturer of medical devices and related software solutions, today announced that the company&rs...

Vic Convertino Presents on New Technology for Early Diagnosis and Treatment of Shock at EMS Today 2015

Vic Convertino, PhD, presented on how the use of intrathoracic pressure regulation (IPR) therapy applied with an impedance threshold device can restore the b...

Taking the Plunge

Over the course of Keith Lurie’s, MD, more than 25-year career, he’s devoted himself to the kinds of research innovations that have saved thousan...

Features by Topic

JEMS Connect




Blogger Browser

Today's Featured Posts

Featured Careers